Snowball logo
logo
0002

Sam Chun Dang Pharm. Co. Ltd

000250 KQ
189,800.00+3,600.00  (1.93%)
Estimate
Beta
1.561
Growth
Revenue, YoY
28.15%
Net income, YoY
1,039.3%
FCF, YoY
-245.05%
Dividends
Dividend yield
0.03%
Annual payout
50.00
Next ex. div date
December 29, 26
Payout
88.4%
Div.rating
About the company
Ticker
000250
ISIN
KR7000250001
Country
South Korea
Sector (GICS)
Healthcare
Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.

Frequently asked questions

What sector does Sam Chun Dang Pharm. Co. Ltd (000250) operate in?

Sam Chun Dang Pharm. Co. Ltd belongs to the Healthcare sector and operates in the Pharmaceuticals industry.

What is Sam Chun Dang Pharm. Co. Ltd (000250) current stock price?

As of the latest data, Sam Chun Dang Pharm. Co. Ltd stock price is ₩189,800, with a previous close of ₩186,200. Sam Chun Dang Pharm. Co. Ltd gained ₩3,600 in the last trading session, representing a 1.93% increase.

What is Sam Chun Dang Pharm. Co. Ltd (000250) current market capitalization?

Sam Chun Dang Pharm. Co. Ltd market cap is approximately 4.06 trillion.

Does Sam Chun Dang Pharm. Co. Ltd (000250) pay dividends?

Yes. Sam Chun Dang Pharm. Co. Ltd pays annual dividends with an annualized yield of 0.03% and an estimated annual payout of ₩50 per share.

When is the next ex-dividend date for Sam Chun Dang Pharm. Co. Ltd (000250)?

The next ex-dividend date is scheduled for December 29, 2026.

What is Sam Chun Dang Pharm. Co. Ltd (000250) beta (volatility) score?

Sam Chun Dang Pharm. Co. Ltd has a beta of 1.561, suggesting it is more volatile than the market.